Evaluation of 611 in Chinese Children and Adolescents With Moderate to Severe Atopic Dermatitis
Clinical trial NCT06324812 · COMPLETED
Trial details
- NCT number
- NCT06324812
- Sponsor
- Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-10
- Primary completion
- 2026-05-25
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.